254 related articles for article (PubMed ID: 19799123)
41. Molecular measurement of minimal residual disease in Philadelphia-positive acute lymphoblastic leukaemia.
Radich JP
Best Pract Res Clin Haematol; 2002 Mar; 15(1):91-103. PubMed ID: 11987918
[TBL] [Abstract][Full Text] [Related]
42. High rate of chromosome abnormalities detected by fluorescence in situ hybridization using BCR and ABL probes in adult acute lymphoblastic leukemia.
Rieder H; Bonwetsch C; Janssen LA; Maurer J; Janssen JW; Schwartz S; Ludwig WD; Gassmann W; Bartram CR; Thiel E; Löffler H; Gökbuget N; Hoelzer D; Fonatsch C
Leukemia; 1998 Sep; 12(9):1473-81. PubMed ID: 9737699
[TBL] [Abstract][Full Text] [Related]
43. [Philadelphia-positive ALL with rearrangement of the 1st intron of the BCR gene].
Valiente A; Escudero A; Benítez J
Sangre (Barc); 1991 Dec; 36(6):505-8. PubMed ID: 1812584
[TBL] [Abstract][Full Text] [Related]
44. The e1a3 BCR-ABL1 fusion transcript in philadelphia chromosome-positive acute lymphoblastic leukemia.
Langabeer SE
Ann Lab Med; 2015 Sep; 35(5):540-1. PubMed ID: 26206693
[No Abstract] [Full Text] [Related]
45. Amplification of BCR-ABL rearrangement in atypical Philadelphia chromosome: a new variant detected by fluorescence in situ hybridization in one case of acute lymphoblastic leukemia.
Poulain S; Daudignon A; Le Baron F; Bisiau H; Simon M; Duthilleul P
Cancer Genet Cytogenet; 1999 Jan; 108(2):158-61. PubMed ID: 9973946
[TBL] [Abstract][Full Text] [Related]
46. BCR-ABL rearrangements in acute lymphoblastic leukaemia.
Lucas GS; Ardern JC
Lancet; 1991 Jun; 337(8756):1548. PubMed ID: 1675396
[No Abstract] [Full Text] [Related]
47. Clinical significance of the BCR-ABL fusion gene in adult acute lymphoblastic leukemia: a Cancer and Leukemia Group B Study (8762).
Westbrook CA; Hooberman AL; Spino C; Dodge RK; Larson RA; Davey F; Wurster-Hill DH; Sobol RE; Schiffer C; Bloomfield CD
Blood; 1992 Dec; 80(12):2983-90. PubMed ID: 1467514
[TBL] [Abstract][Full Text] [Related]
48. Adult acute lymphoblastic leukemia with a rare b3a3 type BCR/ABL1 fusion transcript.
Kurita D; Hatta Y; Hojo A; Kura Y; Sawada U; Kanda Y; Takei M
Cancer Genet; 2016 Apr; 209(4):161-5. PubMed ID: 26854094
[TBL] [Abstract][Full Text] [Related]
49. Genotype-phenotype correlation of unusual BCR-ABL1 transcripts in Philadelphia chromosome-positive leukaemia.
Gong Z; Zhou T; Liu H; Tang G; Yin CC; Wang W; Medeiros LJ; Hu S
Br J Haematol; 2020 Jun; 189(5):e207-e211. PubMed ID: 32237084
[No Abstract] [Full Text] [Related]
50. Genetic heterogeneity of BCR/ABL+ adult B-cell precursor acute lymphoblastic leukemia: impact on the clinical, biological and immunophenotypical disease characteristics.
Primo D; Tabernero MD; Perez JJ; Rasillo A; Sayagués JM; Espinosa AB; Lopez-Berges MC; García-Sanz R; Gutierrez NC; Hernandez JM; Romero M; Osuna CS; Giralt M; Barbon M; San Miguel JF; Orfao A
Leukemia; 2005 May; 19(5):713-20. PubMed ID: 15789066
[TBL] [Abstract][Full Text] [Related]
51. [Detection of minimal residual disease in Ph+/bcr-abl+ acute lymphoblast leukemia by cytogenetic analysis, nested-PCR and flow cytometry].
Xue F; Dong ZR; Zhang B; Gao LX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Aug; 11(4):372-5. PubMed ID: 12962565
[TBL] [Abstract][Full Text] [Related]
52. Philadelphia-positive acute leukemia. Cytogenetic and molecular aspects.
Berger R; Chen SJ; Chen Z
Cancer Genet Cytogenet; 1990 Feb; 44(2):143-52. PubMed ID: 2404570
[No Abstract] [Full Text] [Related]
53. In vitro resistance of leukaemic blasts to prednisolone in bcr-abl positive childhood acute lymphoblastic leukaemia.
Gupta M; Kumar A; Dabadghao S
Indian J Med Res; 2002 Dec; 116():268-72. PubMed ID: 12807155
[TBL] [Abstract][Full Text] [Related]
54. Acquisition of the novel ABL kinase domain mutation T315L in a relapsed Philadelphia-positive acute lymphoblastic leukemia patient.
How GF; Müller MC; Lim LC
Leuk Res; 2012 Jan; 36(1):e20-1. PubMed ID: 21899886
[No Abstract] [Full Text] [Related]
55. A novel e8a2 BCR-ABL1 fusion with insertion of RALGPS1 exon 8 in a patient with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia.
McCarron SL; Kelly J; Coen N; McCabe S; Fay M; O'Dwyer M; Hayden PJ; Langabeer SE
Leuk Lymphoma; 2011 May; 52(5):919-21. PubMed ID: 21338279
[No Abstract] [Full Text] [Related]
56. [Immunophenotypic analysis of Philadelphia chromosome positive acute lymphoblastic leukaemia in adults].
Chen HY; Ge Z; Wu YJ; Wu LY; Sun M; Tian T; Qiou HR; Liu P; Li JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):714-7. PubMed ID: 20561435
[TBL] [Abstract][Full Text] [Related]
57. The e1a3
Chen Z
Hematology; 2023 Dec; 28(1):2186040. PubMed ID: 36912524
[No Abstract] [Full Text] [Related]
58. Molecular and phenotypic spectrum of de novo Philadelphia positive acute leukemia.
Lim LC; Heng KK; Vellupillai M; Tan LT; Boey BC; Lau LC; How GF
Int J Mol Med; 1999 Dec; 4(6):665-7. PubMed ID: 10567681
[TBL] [Abstract][Full Text] [Related]
59. Susceptibility of Ph-positive all to TKI therapy associated with Bcr-Abl rearrangement patterns: a retrospective analysis.
Jing Y; Chen H; Liu M; Zhou M; Guo Y; Gao C; Wang Q; Li H; Zhao Y; Bo J; Huang W; Zhu H; Zhang Y; Yu L
PLoS One; 2014; 9(11):e110431. PubMed ID: 25415187
[TBL] [Abstract][Full Text] [Related]
60. Progression from myelodysplastic syndrome to acute lymphoblastic leukaemia with Philadelphia chromosome and p190 BCR-ABL transcript.
Kohno T; Amenomori T; Atogami S; Sasagawa I; Nakamura H; Kuriyama K; Tomonaga M
Br J Haematol; 1996 May; 93(2):389-91. PubMed ID: 8639433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
